CervicalCheck should begin patient-requested reviews for all invasive cancer diagnoses, including those not detected during routine screening, an expert report has recommended. They were specifically tasked with reviewing the management of interval cancers – those discovered between negative screenings. The report dealing with CervicalCheck has said a process of patient-requested reviews of invasive cancer should be facilitated following receipt of written consent from the patient. “In cancer screening, 11 out of the 17 international programmes that responded to us review cytology [cancer screening], the others did not. Only one of the 17 programmes that do disclose cytology review outcomes do so directly to patients.

Source: The Irish Times October 21, 2020 17:37 UTC